Literature DB >> 15552131

Gentamicin and vancomycin do not impair experimental fracture healing.

Abdul A Haleem1, Mark S Rouse, David G Lewallen, Arlen D Hanssen, James M Steckelberg, Robin Patel.   

Abstract

The purpose of this study was to determine whether gentamicin or vancomycin impair experimental fracture healing in rats. Forty-one male Wistar rats were divided into three groups, receiving either 1.5 mg/kg of gentamicin intramuscularly twice daily for 3 weeks (n = 15), 25 mg/kg of vancomycin intraperitoneally twice daily for 3 weeks (n = 14), or no treatment (n = 12), starting 7 days after production of closed, nondisplaced, bilateral femoral fractures. The mean 30 minute serum concentrations of gentamicin and vancomycin were 4.5 microg/mL and 35.1 microg/mL, respectively. Biomechanical and radiographic studies were used to evaluate fracture healing. Torsional strength testing of fracture callus exposed to gentamicin and vancomycin was similar (437 and 424 N-mm, respectively) to controls (334 N-mm). Radiographs showed similar healing in control animals (Goldberg score, 2.3) compared with rats treated with gentamicin and vancomycin (Goldberg score, 2.6 in both groups). Results of this study do not show impaired healing of experimental fractures after exposure to gentamicin or vancomycin (such as has been reported after exposure to quinolones).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15552131     DOI: 10.1097/01.blo.0000144477.43661.59

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  4 in total

Review 1.  Local Intra-wound Administration of Powdered Antibiotics in Orthopaedic Surgery.

Authors:  Andrew N Fleischman; Matthew S Austin
Journal:  J Bone Jt Infect       Date:  2017-01-01

2.  Study of antibiotic efficacy of topical vancomycin powder in treatment of infected mandibular fractures and soft tissue surgical site infections.

Authors:  Geeta Singh; Deepak Passi; Deepti Daga; Abhigyan Manas; U Vignesh; Sujay Milind Bhave
Journal:  J Family Med Prim Care       Date:  2019-10-31

3.  A biodegradable antibiotic delivery system based on poly-(trimethylene carbonate) for the treatment of osteomyelitis.

Authors:  Daniëlle Neut; Otto S Kluin; Bart J Crielaard; Henny C van der Mei; Henk J Busscher; Dirk W Grijpma
Journal:  Acta Orthop       Date:  2009-10       Impact factor: 3.717

4.  A novel injectable borate bioactive glass cement as an antibiotic delivery vehicle for treating osteomyelitis.

Authors:  Hao Ding; Cun-Ju Zhao; Xu Cui; Yi-Fei Gu; Wei-Tao Jia; Mohamed N Rahaman; Yang Wang; Wen-Hai Huang; Chang-Qing Zhang
Journal:  PLoS One       Date:  2014-01-10       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.